Special Studies in Cancer Patients: AME and Cardiac Safety

FierceBiotech Editor John Carroll will moderate an expert panel discussion exploring how cancer drug developers can best evaluate the safety of a new drug at an early stage of development. Gaining a careful understanding of a therapeutic early on is increasingly important in making a crucial go/no go decision. These experts can help show you how. Register Today